Jazz Pharmaceuticals
JAZZ Large CapHealthcare · Biotechnology
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Jazz Pharmaceuticals Stock at a Glance
Jazz Pharmaceuticals (JAZZ) is currently trading at 172,93 € with a market capitalization of 10,8 Mrd. €. The 52-week range spans from 83,17 € to 176,99 €; the current price is 2.3% below the yearly high. Year-over-year revenue growth stands at +10.1%.
💰 Dividendo
Jazz Pharmaceuticals currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
17 analysts rate Jazz Pharmaceuticals (JAZZ) on consensus: Comprare. The average price target is 192,89 €, implying +11.54% from the current price. Analyst price targets range from 160,37 € to 234,58 €.
Tesi di Investimento: Punti di Forza e Debolezze
- High gross margin of 91.67% — indicates pricing power
- Analyst consensus: Buy
- Positive free cash flow
- –Currently unprofitable
- –Price near 52-week high — limited upside cushion
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior, elevated short interest (9.82%), higher leverage relative to equity.
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Jazz Pharmaceuticals?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
